CMDv questionnaire no. 152 national phase[removed]EMA-CMDv[removed]

First Page		Document Content
Date: 2014-08-22 09:14:45 Pharmaceuticals policy Summary of Product Characteristics Marketing authorization Email Technology Supplementary protection certificate Pharmaceutical industry Pharmacology Pharmaceutical sciences		CMDv questionnaire no. 152 national phase[removed]EMA-CMDv[removed] Add to Reading List Source URL: www.hma.eu Download Document from Source Website File Size: 86,01 KB Share Document on Facebook

	ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 This medicinal product is subject to additional monitoring. This will allow quick identification of DocID: 1trcK - View Document
	ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. DocID: 1tfLD - View Document
	BPGWorksharingEMA-CMDv DocID: 1rr9m - View Document
	B.08 GUIMA Transfer national requirements AT BE CZ DE(BVL, PEI) EE ES FI FR IE IS IT LT LV NL PL RO SE SK SI UKEMA-CMDv DocID: 1rcFm - View Document
	5th World Congress on Medicinal and Aromatic Plants WOCMAP 2014 Brisbane (Australia), 17-20 August 2014 New developments from the European Scientific Cooperative on Phytotherapy DocID: 1qSRs - View Document